AVALONBAY COMM. DL-,01/ US0534841012 /
2024-04-19 7:30:17 PM | Chg. +2.36 | Volume | Bid8:04:09 PM | Ask8:04:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
172.38EUR | +1.39% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 24.57 bill.EUR | - | - |
GlobeNewswire
1:41 AM
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Sharecare, Inc. (...
GlobeNewswire
1:00 AM
StakingFarm to Strengthen Crypto Staking & Holding in Wake of Global Instability
GlobeNewswire
12:56 AM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CI&T Inc Investors to Inquire About Securities Class ...
GlobeNewswire
12:53 AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Autodesk, Inc. Investors to Inquire About Securities Cla...
GlobeNewswire
12:08 AM
ContextLogic Completes Sale of Substantially All Operating Assets and Liabilities Associated with Wi...
GlobeNewswire
12:00 AM
DMOS Revolutionizes Decentralized Computing Landscape with Groundbreaking Cloud Operating System
GlobeNewswire
04-19
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AST SpaceMobile, I...
GlobeNewswire
04-19
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
GlobeNewswire
04-19
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
GlobeNewswire
04-19
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)